TY - JOUR
T1 - The Spectrum of Tuberculosis Disease in an Urban Ugandan Community and Its Health Facilities
AU - Kendall, Emily A.
AU - Kitonsa, Peter J.
AU - Nalutaaya, Annet
AU - Erisa, K. Caleb
AU - Mukiibi, James
AU - Nakasolya, Olga
AU - Isooba, David
AU - Baik, Yeonsoo
AU - Robsky, Katherine O.
AU - Kato-Maeda, Midori
AU - Cattamanchi, Adithya
AU - Katamba, Achilles
AU - Dowdy, David W.
N1 - Funding Information:
Tis work was supported by the National Institutes of Health (grant numbers R01HL138728 to D. W. D. and K08AI127908 to E. A. K.) and by the Fogarty-Fulbright Fellowship in Public Health (award number FIC D43 TW010540 to K. O. R.).
Publisher Copyright:
© 2020 The Author(s). Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
PY - 2021/6/15
Y1 - 2021/6/15
N2 - Background: New, sensitive diagnostic tests facilitate identification and investigation of milder forms of tuberculosis (TB) disease. We used community-based TB testing with the Xpert MTB/RIF Ultra assay ("Ultra") to characterize individuals with previously undiagnosed TB and compare them to those from the same community who were diagnosed with TB through routine care. Methods: We offered community-based sputum Ultra testing to adult residents of a well-defined area (population 34 000 adults) in Kampala, Uganda, via door-to-door screening and venue-based testing, then used detailed interview and laboratory testing to characterize TB-positive individuals. We compared these individuals to residents diagnosed with pulmonary TB at local health facilities and a representative sample of residents without TB (controls). Results: Of 12 032 residents with interpretable Ultra results, 113 (940 [95% confidence interval {CI}, 780-1130] per 100 000) tested positive, including 71 (63%) positive at the lowest (trace) level. A spectrum of TB disease was observed in terms of chronic cough (93% among health facility-diagnosed cases, 77% among residents with positive community-based Ultra results at levels above trace, 33% among trace-positive community participants, and 18% among TB-negative controls), TB symptom prevalence (99%, 87%, 60%, and 38%, respectively), and C-reactive protein (75th percentile: 101 mg/L, 28 mg/L, 6 mg/L, and 4 mg/L, respectively). Community-diagnosed cases were less likely than health facility-diagnosed cases to have human immunodeficiency virus coinfection or previous TB. The specificity of Ultra was 99.4% (95% CI, 99.2%-99.5%) relative to a single spot sputum culture. Conclusions: People with undiagnosed prevalent TB in the community have different characteristics than those diagnosed with pulmonary TB in health facilities. Newer diagnostic tests may identify a group of people with early or very mild disease.
AB - Background: New, sensitive diagnostic tests facilitate identification and investigation of milder forms of tuberculosis (TB) disease. We used community-based TB testing with the Xpert MTB/RIF Ultra assay ("Ultra") to characterize individuals with previously undiagnosed TB and compare them to those from the same community who were diagnosed with TB through routine care. Methods: We offered community-based sputum Ultra testing to adult residents of a well-defined area (population 34 000 adults) in Kampala, Uganda, via door-to-door screening and venue-based testing, then used detailed interview and laboratory testing to characterize TB-positive individuals. We compared these individuals to residents diagnosed with pulmonary TB at local health facilities and a representative sample of residents without TB (controls). Results: Of 12 032 residents with interpretable Ultra results, 113 (940 [95% confidence interval {CI}, 780-1130] per 100 000) tested positive, including 71 (63%) positive at the lowest (trace) level. A spectrum of TB disease was observed in terms of chronic cough (93% among health facility-diagnosed cases, 77% among residents with positive community-based Ultra results at levels above trace, 33% among trace-positive community participants, and 18% among TB-negative controls), TB symptom prevalence (99%, 87%, 60%, and 38%, respectively), and C-reactive protein (75th percentile: 101 mg/L, 28 mg/L, 6 mg/L, and 4 mg/L, respectively). Community-diagnosed cases were less likely than health facility-diagnosed cases to have human immunodeficiency virus coinfection or previous TB. The specificity of Ultra was 99.4% (95% CI, 99.2%-99.5%) relative to a single spot sputum culture. Conclusions: People with undiagnosed prevalent TB in the community have different characteristics than those diagnosed with pulmonary TB in health facilities. Newer diagnostic tests may identify a group of people with early or very mild disease.
KW - Xpert MTB/RIF Ultra
KW - active case-finding
KW - prevalent tuberculosis
KW - subclinical tuberculosis
UR - http://www.scopus.com/inward/record.url?scp=85105908415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105908415&partnerID=8YFLogxK
U2 - 10.1093/cid/ciaa1824
DO - 10.1093/cid/ciaa1824
M3 - Article
C2 - 33283227
AN - SCOPUS:85105908415
SN - 1058-4838
VL - 72
SP - E1035-E1043
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 12
ER -